SCHEMBL6282517

SCHEMBL6282517

CC1(C)C2CCC(N)CC21

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22548038 0.73 CDK5 (0.37) KMT2A
SCHEMBL12501529 0.72
SCHEMBL8893 0.70 ABCB1 (0.36)
SCHEMBL20096241 0.68
SCHEMBL20096233 0.68
SCHEMBL16358128 0.67
Hydrochloric Acid SCHEMBL25233458 0.67
Hydrogen Peroxide SCHEMBL9193981 0.67 ABCB1 (0.34) KMT2A
Hydrochloric Acid SCHEMBL31645494 0.67
SCHEMBL16338940 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6916838-B1 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists SANOFI-AVENTIS (FR) 2005-07-12 US disclosed
EP-1230222-B1 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS SANOFI SYNTHELABO (FR) 2004-07-07 EP disclosed
EP-1230222-A1 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS SANOFI-SYNTHELABO (FR) 2002-08-14 EP disclosed
WO-2001032629-A1 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS SANOFI-SYNTHELABO (FR) 2001-05-10 WO disclosed